Consensus guidelines for oral dosing of primarily renally cleared medications in older adults

Journal of the American Geriatrics Society

Volumn 57, Issue 2, 2009, Pages 335-340

  Hanlon, Joseph T ^a,b,d,e   Aspinall, Sherrie L ^b,e,f   Semla, Todd P ^f   Weisbord, Steven D ^a,e   Fried, Linda F ^a,e   Good, C Bernie ^a,e,f   Fine, Michael J ^a,e   Stone, Roslyn A ^c,e   Pugh, Mary Jo V ^g   Rossi, Michelle I ^a,b,c   Handler, Steven M ^a,b  

^a UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF PITTSBURGH   (United States)

^c UNIVERSITY OF PITTSBURGH GRADUATE SCHOOL OF PUBLIC HEALTH   (United States)

^d GERIATRIC RESEARCH EDUCATION AND CLINICAL CENTER   (United States)

^e VETERANS AFFAIRS MEDICAL CENTER   (United States)

^f Veterans Affairs Center for Medication Safety   (United States)

^g UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO   (United States)

Author keywords

Aged; Chronic kidney disease; Suboptimal prescribing

Indexed keywords

ACICLOVIR; AMANTADINE; CHLORPROPAMIDE; CIPROFLOXACIN; COLCHICINE; COTRIMOXAZOLE; DEXTROPROPOXYPHENE; GABAPENTIN; GLIBENCLAMIDE; MEMANTINE; NITROFURANTOIN; PETHIDINE; PROBENECID; RANITIDINE; RIMANTADINE; SPIRONOLACTONE; TRIAMTERENE; VALACICLOVIR;

ARTICLE; CHRONIC KIDNEY DISEASE; HEALTH SURVEY; KIDNEY FUNCTION; PRACTICE GUIDELINE; PRESCRIPTION;

ADMINISTRATION, ORAL; AGED; AGED, 80 AND OVER; DELPHI TECHNIQUE; HUMANS; KIDNEY; PHARMACEUTICAL PREPARATIONS;

EID: 58849128272     PISSN: 00028614     EISSN: 15325415     Source Type: Journal    
DOI: 10.1111/j.1532-5415.2008.02098.x     Document Type: Article

References (37)

1. Stevens LA, Levey AS. Chronic kidney disease in the elderly-how to assess risk. N Engl J Med 2005 352 : 2122 2124.
2. Wong N, Jones H. An analysis of discharge drug prescribing amongst elderly with renal impairment. Postgrad Med J 1998 49 : 420 422.
3. Papaioannou A, Clarke JA, Campbell G et al. Assessment of adherence to renal dosing guidelines in long-term care facilities. J Am Geriatr Soc 2000 48 : 1470 1473.
4. Vidal L, Shavit M, Fraser A et al. Systematic comparison of drug information regarding adjustment of dose for renal function. BMJ 2005 331 : 263 266.
5. Jones J, Hunter D. Consensus methods for medical and health services research. BMJ 1995 311 : 376 380.
6. Campbell SM, Cantrill JA. Consensus methods in prescribing research. J Clin Pharm Ther 2001 26 : 5 14.
7. Delbecq AL, Van de Ven AH, Gustafson DH. Group Techniques for Program Planning: A Guide to Nominal Group and Delphi Processses. Glenview, IL : Scott Foresman, 1975.
8. Fouts MM, Hanlon JT, Pieper CF et al. Identification of elderly nursing facility residents at high risk for drug-related problems. Consult Pharm 1997 12 : 1103 1111.
9. Hajjar E, Artz MB, Lindblad CI et al. Risk factors and prevalence for adverse drug reactions in an ambulatory elderly population. Am J Geriatr Pharmacother 2003 1 : 82 89.
10. Lindblad CI, Hanlon JT, Gross CR et al. Clinically serious drug disease interactions in the elderly: Opinion of a consensus panel. Clin Ther 2006 28 : 1133 1143.
11. Handler SM, Hanlon JT, Perera S et al. Consensus list of signals to detect potential adverse drug reactions in nursing homes. J Am Geriatr Soc 2008 56 : 808 815.
12. McGlynn EA, Asch SM. Developing a clinical performance measure. Am J Prev Med 1998 14 : 14 21.
13. Higashi T, Shekelle PG, Solomon DH et al. The quality of pharmacologic care for vulnerable older patients. Ann Intern Med 2004 140 : 714 720.
14. Fick DM, Cooper JW, Wade WE et al. Updating the Beers criteria for potentially inappropriate medication use in older adults: Results of a US consensus panel of experts. Arch Intern Med 2003 163 : 2716 2724.
15. Aronoff GR, Bennett WM, Berns JS et al., eds. Drug Prescribing in Renal Failure, 5th Ed. Philadelphia : American College of Physicians Press, 2007.
16. Semla TP, Beizer JL, Higbee MD. Geriatric Dosage Handbook, 12th Ed. Hudson, OH : Lexicomp, 2007.
17. Jamal SA, Bauer DC, Ensrud KE et al. Alendronate treatment in women with normal to severely impaired renal function: An analysis of the Fracture Intervention Trial. J Bone Miner Res 2007 22 : 503 508.
18. Miller PD, Roux C, Boonen S et al. Safety and efficacy of risedronate in patients with age-related reduced renal function as estimated by the Cockcroft and Gault method: A pooled analysis of nine clinical trials. J Bone Min Res 2005 20 : 2105 2115.
19. Strampel W, Emkey R, Civitelli R et al. Safety considerations with bisphosphonates for the treatment of osteoporosis. Drug Safety 2007 30 : 755 763.
20. Gangji AS, Cukierman T, Gerstein HC et al. A systematic review and meta-analysis of hypoglycemia and cardiovascular events: A comparison of glyburide with other secretagogues and with insulin. Diabetes Care 2007 30 : 389 394.
21. Juurlink DN, Mamdani MM, Lee DS et al. Rates of hyperkalemia after publication of the Randomized Aldactone Evaluation Study. N Engl J Med 2004 351 : 543 551.
22. Periclou A, Ventura D, Rao N et al. Pharmacokinetic study of memantine in health and renally impaired subjects. Clin Phamacol Ther 2006 79 : 134 143.
23. Hanlon JT, Guay DRP, Ives T. Oral analgesics: Efficacy, mechanism of action, pharmacokinetics, adverse effects, drug interactions, and practical recommendations for use in older adults. In : Gibson SJ, Weiner DK, eds. Pain in Older Persons, Progress in Pain Research and Management, Vol. 35. Seattle : IASP Press, 2005, pp 205 222.
24. Day RO, Graham GG, Hicks M et al. Clinical pharmacokinetics and pharmacodynamics of allopurinol and oxypurinol. Clin Pharmacokin 2007 46 : 623 644.
25. Chung Y, Stocker SL, Graham GG et al. Optimizing therapy with allopurinol: Factors limiting hypouricemic efficacy. Am J Med Sci 2008 335 : 219 226.
26. Jones B, Nanra RS. Double blind trial of antihypertensive effect of chlorothiazide in severe renal failure. Lancet 1979 2 : 1258 1260.
27. Fliser D, Schröter M, Neubeck M et al. Coadministration of thiazides increases the efficacy of loop diuretics even in patients with advanced renal failure. Kidney Int 1994 46 : 482 488.
28. Salpeter SR, Greyber E, Pasternak GA et al. Risk of fatal and nonfatal lactic acidosis with metformin use in type 2 diabetes mellitus: Systematic review and meta-analysis. Cochrane Database Syst Rev, 2006. Issue 1. Art. No.: CD002967. DOI :.
29. Cockcroft DW, Gault MH. Predicting creatinine clearance from serum creatinine. Nephron 1976 16 : 31 41.
30. May TW, Rambeck B, Neb R et al. Serum concentrations of pregabalin in patients with epilepsy: The influence of dose, age, and comedication. Ther Drug Monit 2007 29 : 789 794.
31. Matzke GR, Halstenson CE, Opsahl JA et al. Pharmacokinetics of loratadine in patients with renal insufficiency. J Clin Pharmacol 1990 30 : 364 371.
32. Hilbert J, Moritzen V, Parks A et al. The pharmacokinetics of loratadine in normal geriatric volunteers. J Int Med Res 1988 16 : 50 60.
33. Chertow GM, Lee J, Kuperman GJ et al. Guided medication dosing for inpatients with renal insufficiency. JAMA 2001 286 : 2839 2844.
34. Field TS, Rochon P, Lee M et al. Costs associated with developing and implementing a computerized clinical decision support system for medication dosing for patients with renal insufficiency in the long-term care setting. J Am Med Inform Assoc 2008 15 : 466 472.
35. Chaudhry B, Wang J, Wu S et al. Systematic review: Impact of health information technology on quality, efficiency, and costs of medical care. Ann Intern Med 2006 144 : 742 752.
36. Durieux P, Trinquart L, Colombet I et al. Computerized advice on drug dosage to improve prescribing practice. Cochrane Database Syst Rev, 2008. CD002894.
37. Matheny ME, Sequist TD, Seger AC et al. A randomized trial of electronic clinical reminders to improve medication laboratory monitoring. J Am Med Inform Assoc 2008 15 : 424 429.